Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

Canada: A landmark population-based study published in The Lancet Child & Adolescent Health has revealed that children and ...

A phase 2 trial evaluated the efficacy and safety of lorundrostat in hypertensive patients with chronic kidney disease (CKD) and albuminuria.

The Department of Health (DOH) has raised concern over the increasing number of chronic kidney disease (CKD) cases in the ...

Kidney cancer, can happen due to various reasons, one of them is Chronic Kidney Disease. CKD can lead to gradual kidney ...

Here's what kidney stones are, what causes them and how you can expect to have them treated if they affect you or someone you ...

Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...

References: Lebel A, Chanchlani R, Cockovski V, et al. Chronic kidney disease or hypertension after childhood cancer. JAMA Netw Open. Published online May 19, 2025. doi:10.001/jamanetworkopen.2025 ...

Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable ...

Studies show that chronic high blood pressure (hypertension) is associated with a significantly increased risk of renal cell ...

Salt substitutes can reduce your blood pressure and risk of heart disease and stroke. These include citrus, herbs, vinegar, ...

Chen also says that air pollution harms blood vessels, including the tiny ones in the kidneys, which can reduce blood flow ...